Stock listing
OTC:TSOI Therapeutic Solutions International, Inc. Stock
Follow Therapeutic Solutions International, Inc. into a list and get an email when it puts out news.

- Ticker
- OTC:TSOI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 12 slides
Latest news
Therapeutic Solutions International, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in all · newest Apr 23, 2025 · oldest 2025
- Decks
- 1 deck · latest September 2026
Events
| Quarter | Results |
|---|---|
| Q3 2024 | Nov 12, 2024 · Before open |
| Q2 2024 | Aug 19, 2024 · After close |
| Q1 2024 | May 30, 2024 · After close |
| Q4 2023 | Mar 29, 2024 · After close |
| Q3 2023 | Nov 14, 2023 · Before open |
| Q2 2023 | Aug 21, 2023 · After close |
| Q1 2023 | May 16, 2023 · After close |
| Q4 2022 | Mar 29, 2023 |
| Q3 2022 | Nov 17, 2022 |
| Q2 2022 | Aug 19, 2022 |
All 16 quarters
| Quarter | Results |
|---|---|
| Q1 2022 | May 23, 2022 |
| Q4 2021 | Mar 31, 2022 |
| Q3 2021 | Nov 22, 2021 |
| Q2 2021 | Aug 13, 2021 |
| Q1 2021 | Apr 9, 2021 |
| Q4 2020 | Mar 31, 2021 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2026) | Investor deck | 12 slides | September 2026 |
Financials
Annual, in USD
Income statement
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 99.0K | 206.8K | 146.0K | 62.7K | 27.5K | 3.48K | 2.85K | 1.91K | 268.9K | 0 |
| Cost of revenue | 36.8K | 79.4K | 42.5K | 12.8K | 3.02K | 2.16K | 823 | 3.19K | 26.8K | 0 |
| Gross profit | 62.2K | 127.3K | 103.4K | 49.9K | 24.5K | 1.33K | 2.03K | -1.28K | 242.1K | 0 |
| Research and development | 560.7K | 1.44M | 794.8K | 562.0K | 27.7K | 75.0K | 25.1K | 11.0K | 11.0K | 11.0K |
| Selling, general and administrative | 1.05M | 1.77M | 1.61M | 1.34M | 1.04M | 1.12M | 857.9K | 565.8K | 306.0K | 306.0K |
| Operating income | -1.99M | -3.28M | -2.30M | -1.85M | -1.04M | -1.20M | -884.3K | -570.9K | -327.1K | -327.1K |
| Depreciation and amortization | 311.8K | 244.6K | 18.1K | 6.98K | 6.59K | 195.0K | 27.5K | 1.04M | 21.1K | 21.1K |
| EBITDA | -1.67M | -3.03M | -2.29M | -1.84M | -1.04M | -1.00M | -856.8K | 471.2K | -306.0K | -306.0K |
| Interest expense | 423.3K | 646.1K | 611.8K | 302.5K | 350.7K | 241.8K | 53.4K | 5.55K | 9.38K | 0 |
| Income before tax | -2.22M | -3.88M | -2.96M | -2.20M | -1.70M | -1.87M | -995.5K | -572.6K | -537.8K | -537.8K |
| Income tax | 2.25K | 1.60K | 800 | 295.8K | 350.7K | 667.1K | -830.8K | 13.8K | 14.3K | 0 |
| Net income | -2.17M | -3.81M | -2.96M | -2.20M | -1.70M | -1.87M | -995.5K | -586.4K | -288.8K | -288.8K |
| Earnings per share, basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Balance sheet
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 27.8K | 18.0K | 94.0K | 252.1K | 26.4K | 22.4K | 29 | 21.9K | 2.89K | 2.89K |
| Short-term investments | 0 | 0 | 0 | 0 | ||||||
| Receivables | 19.2K | 25.4K | 16.6K | 2.44K | 2.90K | -1.05K | -14.3K | 90.0K | ||
| Inventory | 22.6K | 42.4K | 39.8K | 5.40K | 5.18K | 0 | 1.51K | 36.4K | 26.8K | |
| Current assets | 85.9K | 309.2K | 1.12M | 347.5K | 139.7K | 135.9K | 2.60K | 72.6K | 188.8K | 188.8K |
| Property, plant and equipment | 281.7K | 318.2K | 64.0K | 5.62K | 0 | 0 | 0 | 0 | ||
| Goodwill | 0 | 0 | 0 | 0 | ||||||
| Total assets | 3.29M | 3.61M | 1.72M | 603.5K | 311.0K | 206.9K | 26.5K | 104.9K | 201.2K | 201.2K |
| Accounts payable | 404.9K | 409.2K | 403.8K | 309.7K | 324.9K | 320.8K | 343.8K | 327.6K | 290.6K | 290.6K |
| Current liabilities | 1.90M | 2.21M | 2.50M | 2.35M | 2.35M | 2.02M | 1.34M | 684.2K | 332.5K | 332.5K |
| Long-term debt | 5.51K | 10.5K | 15.5K | 0 | 0 | 75.5K | 0 | |||
| Total debt | 888.1K | 1.08M | 1.10M | 1.04M | 981.6K | 504.3K | 456.7K | 297.0K | 30.0K | |
| Total liabilities | 2.01M | 2.22M | 2.52M | 2.38M | 2.35M | 2.02M | 1.34M | 759.7K | 332.5K | 332.5K |
| Shareholders' equity | 1.13M | 1.22M | -805.0K | -1.78M | -2.04M | -1.81M | -1.31M | -654.8K | -131.3K | -131.3K |
| Shares outstanding | 3.17B | 2.53B | 2.26B | 1.91B | 1.28B | 896.9M | 778.2M | 668.1M | 196.4M |
Cash flow
| Line | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.06M | -1.02M | -718.9K | -663.1K | -310.7K | -469.2K | -366.7K | -385.7K | -59.6K | -332.5K |
| Capital spending | -16.2K | -200.0K | -260.6K | -5.45K | -5.45K | -5.45K | -5.45K | 0 | 0 | 0 |
| Free cash flow | -1.07M | -1.02M | -979.5K | -668.5K | -310.7K | -469.2K | -366.7K | -385.7K | -59.6K | -332.5K |
| Cash from investing | -24.0K | -256.6K | -5.45K | -5.45K | -5.45K | -5.45K | 0 | 55.0K | 55.0K | |
| Cash from financing | 1.08M | 943.1K | 817.4K | 894.3K | 314.7K | 491.5K | 344.8K | 405.5K | -5.00K | 267.9K |
| Dividends paid | 0 | 0 | 0 | 0 | ||||||
| Share buybacks | 588.0K | 0 | 1.70K | 2.82K | 1.68K | 202.5K | ||||
| Change in cash | -1.61K | -75.2K | -158.1K | 225.8K | 4.03K | 22.4K | -21.9K | 19.7K | -9.62K | -9.62K |
Cap table
Built by 6ix from Therapeutic Solutions International, Inc.’s releases
- Common shares
- 5,122,705,536
- Fully diluted
- 5,122,705,536
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,122,705,536 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,122,705,536 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gerry B Berg Other companies: Dakota Territory Resource Corp (Director · Nov 12, 2012 – Nov 12, 2012 · Past) | CFO, Director · Nov 21, 2011 – Jan 3, 2019 · Past |
| Thomas Ichim | Director · Oct 16, 2023 – Oct 1, 2024 · Past |
Log in to ask 6ix AI your own questions about Therapeutic Solutions International, Inc.